Spampinato, M.; Carota, G.; Sferrazzo, G.; Fuochi, V.; Distefano, A.; Ronsisvalle, S.; Sipala, F.; Giuffrida, R.; Furneri, P.M.; Di Rosa, M.;
et al. Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells. Pharmaceutics 2022, 14, 2845.
https://doi.org/10.3390/pharmaceutics14122845
AMA Style
Spampinato M, Carota G, Sferrazzo G, Fuochi V, Distefano A, Ronsisvalle S, Sipala F, Giuffrida R, Furneri PM, Di Rosa M,
et al. Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells. Pharmaceutics. 2022; 14(12):2845.
https://doi.org/10.3390/pharmaceutics14122845
Chicago/Turabian Style
Spampinato, Mariarita, Giuseppe Carota, Giuseppe Sferrazzo, Virginia Fuochi, Alfio Distefano, Simone Ronsisvalle, Federica Sipala, Rosario Giuffrida, Pio Maria Furneri, Michelino Di Rosa,
and et al. 2022. "Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells" Pharmaceutics 14, no. 12: 2845.
https://doi.org/10.3390/pharmaceutics14122845
APA Style
Spampinato, M., Carota, G., Sferrazzo, G., Fuochi, V., Distefano, A., Ronsisvalle, S., Sipala, F., Giuffrida, R., Furneri, P. M., Di Rosa, M., Tibullo, D., Li Volti, G., & Barbagallo, I.
(2022). Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells. Pharmaceutics, 14(12), 2845.
https://doi.org/10.3390/pharmaceutics14122845
